YBX1 and colorectal carcinoma: H3K18la also contributes to cisplatin resistance by inducing transcription factor Y-box binding protein 1 (YBX1) and YY1 in bladder cancer43, and H4K12la increases ATP-binding cassette (ABC) transporter expression, rendering CRC resistant to chemotherapy (Fig. 2d)44.